Tue, April 30, 2024
Mon, April 29, 2024
Fri, April 26, 2024

Evan David Seigerman Maintained (ABBV) at Buy with Decreased Target to $180 on, Apr 29th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-180-on-apr-29th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Evan David Seigerman of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $195 to $180 on, Apr 29th, 2024.

Evan has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Evan's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Evan


  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
  • Gary Nachman of "Raymond James" Maintained at Buy with Increased Target to $189 on, Tuesday, February 6th, 2024
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $195 on, Tuesday, February 6th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $200 on, Monday, February 5th, 2024
  • Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 29th, 2024

Publication Contributing Sources